#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Mark Exley Email
Chief Scientific Officer . Imvax
Philadelphia, PA
LocationPrimary Email
How to contact Mark Exley
Join and see Mark's contact info for free!Current Roles
Employees:
59Revenue:
$4.6MAbout
The approach is an autologous, cell-based treatment that activates the full array of patient-specific antigens, resulting in both an innate and adaptive immune response. The company's lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer with a significant unmet need. In parallel, the company is also progressing the platform in a select number of additional solid tumors where the unmet need remains great and where initial immunotherapy approaches have often failed to provide a significant benefit.Imvax Address
601 Walnut StPhiladelphia, PA
United States